GlassScriptPhysician profile
Ninoutchka Dejean
NPI 1285811232
$1,326.40
in general payments reported to CMS, 2019-2025
16 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $64.04 · 2021: $119 · 2022: $212 · 2023: $258 · 2024: $120 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.12 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $285.74 | 2022-2025 | Nextstellis, Annovera |
| Hologic Sales and Service, LLC | $156.68 | 2019-2025 | Myosure Tissue Removal Device, Novasure |
| Agile Therapeutics, INC. | $133.38 | 2021-2024 | Twirla |
| Exact Sciences Corporation | $131.38 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $126.97 | 2021-2024 | Slynd, Tyblume |
| Viiv Healthcare Company | $76.77 | 2022-2025 | Apretude |
| Lupin INC. | $68.90 | 2019-2021 | |
| Avion Pharmaceuticals | $67.88 | 2019-2022 | |
| Therapeuticsmd, INC. | $56.32 | 2019 | |
| Scynexis, INC. | $51.98 | 2022 | |
| Abbvie INC. | $51.41 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $50.19 | 2020-2023 | |
| Allergan, INC. | $23.00 | 2019 | |
| Astellas Pharma US INC | $16.57 | 2023 | Veozah |
| Meditrina | $15.88 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ninoutchka Dejean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.